Skip to content

A cohort study of intermittent exotropia treatment methods and prognosis

A cohort study on the prognosis of patients with intermittent exotropia with different treatment methods

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066372
Enrollment
Unknown
Registered
2022-12-02
Start date
2022-12-05
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intermittent exotropia

Interventions

active observation :active observation
prism group:with prism
surgery group:with surgery

Sponsors

2nd Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 15 Years

Inclusion criteria

Inclusion criteria: 1. 3-15-year-old IXT patients with normal growth and development without intellectual disability 2. The best corrected visual acuity in one eye reaches the level of normal children of the same age. If the child cannot recognize the eye chart, both eyes should have good gaze function 3. Patients with intermittent exotropia who have not received any previous treatment (except for conventional refractive correction) 4. Parents have the ability to read and understand Chinese; 5. Consent to participate in this research

Exclusion criteria

Exclusion criteria: 1. Combined with other eyeballs, extraocular muscles and orbital diseases (except refractive errors) 2. Patients who cannot cooperate with examination and follow-up 3. Combined facial deformities 4. The BCVA difference between the two eyes is =2 lines 5. Patients with vertical strabismus =5PD 6. anisometropia = 2D 7. Associated with neurodevelopmental disorders 8. Constant exotropia (except slight squint); 9. Children with exotropia with insufficient aggregation (the degree of near-strabismus is greater than that of far-strabismus>10PD); 10. Patients who are participating in other clinical trials;

Design outcomes

Primary

MeasureTime frame
deviation;controlling score;sphere equivalent;axial length;binocular vision;

Secondary

MeasureTime frame
AC/A ratio;square of quality of life;

Countries

China

Contacts

Public ContactLi Yunping

2nd Xiangya Hospital, Central South University

amyli2006@hotmail.com15874968585

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026